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Primary Extraskeletal Mesenchymal
Chondrosarcoma Arising from the
Pancreas
We report here on a case of primary extraskeletal mesenchymal chondrosarco-
ma that arose from the pancreas. A 41-year-old man was evaluated by CT to find
the cause of his abdominal pain. The CT scans showed a heterogeneously
enhancing necrotic mass with numerous areas of coarse calcification, and this
was located in the left side of the retroperitoneal space and involved the body and
tail of the pancreas. Portal venography via the celiac axis also showed invasion of
the splenic vein. Following excision of the mass, it was pathologically confirmed
to be primary extraskeletal mesenchymal chondrosarcoma that arose from the
pancreas. 
esenchymal chondrosarcoma is a rare and more aggressive variant of
conventional chondrosarcoma. It represents approximately 1% of all
chondrosarcomas and it carries a poor prognosis. It can occur in
extraskeletal locations and mainly in the soft tissues of the orbit, the cranial and spinal
meningeal coverings and the lower limbs (1, 2). To the best of our knowledge, there
has been no reported case of primary extraskeletal mesenchymal chondrosarcoma of
the pancreas. Only two instances of metastatic chondrosarcomas in the pancreas have
been reported in the literature (3, 4). We report here on a case of primary mesenchy-
mal chondrosarcoma arising from the pancreas in a 41-year-old man.
CASE REPORT
A 41-year-old man presented with a 1-month history of abdominal pain. His
previous medical and familial histories were unremarkable. Unenhanced transverse
CT scan of the abdomen revealed an ill defined, lobulated mass that measured about
13 12 7 cm in size and it appeared as a heterogeneously low attenuated mass with
numerous areas of coarse calcification. It was located in the left side of the retroperi-
toneal space and involved the body and tail of the pancreas (Fig. 1A). Contrast-
enhanced CT was performed after mechanical injection of 130 cc of nonionic
iopromide (300 mg/ml of iodine) into the antecubital vein at a rate of 2.65 ml/sec.
After initiating infusion of contrast material, we used scanning delays of 30 seconds
before starting to obtain the arterial phase images. Imaging in the portal venous phase
was performed after a scanning delay of 70 seconds from the initiation of infusion of
contrast material. On the contrast-enhanced transverse CT scan obtained during the
portal venous phase, subtle enhancement was noted in only the periphery of the mass
and most of the mass remained without enhancement (Fig. 1B). The contrast-enhanced
coronal reformatted image showed the ill defined necrotic low attenuated mass with
obliteration of the splenic vein by the mass, and there was the development of
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Fig. 1. A. Unenhanced transverse CT scan reveals an ill defined, lobulated mass (arrowheads) of heterogeneously low attenuation that
contains numerous areas of coarse calcification (arrows) in the left side of the retroperitoneum. 
B. On the contrast-enhanced transverse CT scan obtained during the portal venous phase, subtle enhancement is only noted in the
periphery of the mass (arrows), and most of the mass remains without enhancement. 
C. The contrast-enhanced coronal reformatted image shows the ill defined necrotic low attenuated mass (arrowheads) and obliteration of
the splenic vein by the mass (thick arrow) with the development of multiple collateral veins (thin arrows). 
D. Portal venography via the celiac axis also shows obliteration of the splenic vein (thick arrow) by the mass and the development of
multiple collateral veins (thin arrows). 
E. A large multilobulated mass (arrowheads) is located in the body and tail of the pancreas with attachment to the spleen (asterisk) and
transverse colon (arrows). 
F. Light microscopic image shows the typical bimorphic pattern of chondrosarcoma. The chondroid zone (A) is surrounded by a prolifera-
tion of undifferentiated cells (B) with abrupt transition. (Hematoxylin & Eosin staining,  100)
EFmultiple collateral veins (Fig. 1C). Portal venography via
the celiac axis also showed tumor invasion to the splenic
vein (Fig. 1D). The patient underwent exploratory laparo-
tomy and mass excision was done. The specimen was
revealed to be a large, firm, fixed hypervascular mass
arising from the pancreas, and it occupied the left upper
quadrant of the abdomen. A large multilobulated mass that
measured 15 cm in maximum diameter was located in the
body and tail of the pancreas, and it was attached to the
spleen and transverse colon (Fig. 1E). Microscopically, the
chondroid zone was surrounded by proliferation of
undifferentiated cells with abrupt transition (Fig. 1F). The
pathological diagnosis was extraskeletal mesenchymal
chondrosarcoma arising from the pancreas with invasion to
the splenic vein.
DISCUSSION
Mesenchymal chondrosarcoma was first reported by
Lichtenstein and Bernstein in 1959 (5) and this type of
tumor discovered in the soft tissue by Dowling in 1964 (6).
It is an uncommon tumor of the bone and soft tissues, and
is defined as the coexistence of nests of well-defined
cartilaginous tissue within a proliferation of primitive
mesenchymal cells. Mesenchymal chondrosarcoma is a
malignant neoplasm with high metastatic potential, particu-
larly to the lungs, and it tends to occur preferentially in
bones and soft tissues (1). In contrast to conventional
chondrosarcoma for which only 1% of tumors are
extraskeletal, mesenchymal chondrosarcoma developed in
the soft tissues in almost half the reported cases (2).
Extraskeletal mesenchymal chondrosarcomas are located
mainly in the soft tissues of the orbit, the cranial and spinal
meningeal coverings, and the lower limbs, and particularly
the thigh. In the rare instances, this type of tumor has been
found in the mediastinum, hand musculature, retroperi-
toneum and kidney (1). Extraskeletal mesenchymal
chondrosarcoma affects women slightly more often than
men, whereas men are predominate for skeletal and
extraskeletal conventional chondrosarcoma (7).
Extraskeletal mesenchymal chondrosarcoma has two peak
age incidences in adults, depending on its location: at 23.5
years for central nervous system involvement and at 43.9
years for soft-tissue and/or muscular involvement (8).
Mesenchymal chondrosarcoma, regardless of its origin,
often displays a lethal clinical course with a 5-year survival
rate of 55% and a 10-year survival rate of 27% (5); radical
excision of the tumor is the recommended treatment (7). 
Conventional radiography, CT and magnetic resonance
of extraskeletal mesenchymal chondrosarcoma
demonstrate several overlapping features with those of
conventional chondrosarcoma (9). Conventional radiogra-
phy and CT depict extraskeletal mesenchymal chondrosar-
coma as a soft-tissue mass with ring, arc, stippled and
highly opaque calcifications. Contrast-enhanced CT depicts
a soft tissue mass that consists of an enhancing viable
tumor portion in the periphery and central focal low
attenuation areas that possibly represent necrosis (2). Our
patient showed similar CT findings. Extraskeletal
mesenchymal chondrosarcoma also shares imaging findings
with other skeletal and soft-tissue tumors. Chondroid-type
calcifications and lobulation are features of both benign
and malignant cartilaginous tumors, although these tumors
are not usually found in extraskeletal locations (2). Their
gross appearance is often large (nearly 10 cm at the
greatest dimension), lobulated and well circumscribed, and
they contain cartilaginous foci. The histologic diagnosis is
definitive, showing a combination of highly cellular,
undifferentiated mesenchymal cells and islands of well-
differentiated cartilage (9). Histologically it is defined by
the coexistence of nests of well-defined cartilaginous tissue
and calcification within a proliferation of primitive or
undifferentiated mesenchymal cells (1). 
Although the imaging findings of lobulated, enhancing
masses with cartilaginous calcifications on plain
radiographs and CT scans are not specific for extraskeletal
mesenchymal chondrosarcoma, they could reflect the
unique histopathologic characteristics of vascular undiffer-
entiated mesenchyme that surrounds foci of differentiated
cartilage (2). 
In summary, we present here a case of primary
extraskeletal mesenchymal chondrosarcoma that arose
from the pancreas. Radiologically, it manifested as a
necrotic soft tissue mass with chondroid calcifications. 
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